This study represents the first successful induction of tau-mediated neuronal death in human iPSC-derived neurons using wild-type tau, establishing a robust and efficient model for drug discovery targeting tauopathies and other neurodegenerative diseases. This evidence concerns the gene MAPT and neurodegenerative disease.